Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting
Previously, we showed that serum soluble interleukin-2 receptor (sIL-2R) levels, a marker for T-cell activation, were higher in complex regional pain syndrome (CRPS) patients than in healthy controls, suggesting pathogenic T-cell activation in CRPS. Additionally, sIL-2R levels discriminated well bet...
Saved in:
Main Authors: | K. D. Bharwani (Author), M. Dirckx (Author), D. L. Stronks (Author), W. A. Dik (Author), F. J. P. M. Huygen (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes?
by: Krishna D. Bharwani, et al.
Published: (2017) -
The Prevalence of Autoantibodies in Complex Regional Pain Syndrome Type I
by: Maaike Dirckx, et al.
Published: (2015) -
Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
by: T. Robak, et al.
Published: (1998) -
Serum Interleukin-6 in Patients with Burning Mouth Syndrome and Relationship with Depression and Perceived Pain
by: Qianming Chen, et al.
Published: (2007) -
Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease
by: A. F. Karim, et al.
Published: (2018)